Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine. Clinics [Internet]. 2022 Feb. 2 [cited 2024 Jun. 9];77:100007. Available from: https://journals.usp.br/clinics/article/view/213624